Jeffrey A. Silverman
Profile
Jeffrey A.
Silverman worked as the VP of Clinical Pharmacology & Translational Research at Talon Therapeutics, Inc. He holds a doctorate degree from the University of Pittsburgh and an undergraduate degree from Colorado State University.
Former positions of Jeffrey A. Silverman
| Companies | Position | End |
|---|---|---|
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Chief Tech/Sci/R&D Officer | 10/05/2012 |
Training of Jeffrey A. Silverman
| Colorado State University | Undergraduate Degree |
| University of Pittsburgh | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey A. Silverman
